Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-16-022948)

Filing Details

Accession Number:: 0000899243-16-022948
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-06-15 17:00:20
Reporting Period:: 2016-06-13

Filing Date:: 2016-06-15
Accepted Time:: 2016-06-15 17:00:20
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1583648	Pieris Pharmaceuticals Inc.	PIRS	Services-Commercial Physical & Biological Research (8731)	300784346

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1650991	Louis Matis	C/O Pieris Pharmaceuticals, Inc. 255 State Street, 9Th Floor Boston MA 02109	Svp, Chief Development Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-06-13	2,085	$1.68	2,085	No	4	P	Direct
Common Stock	Acquisiton	2016-06-14	7,915	$1.71	10,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.67 to $1.72, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges sent forth in this footnote.